A case of disseminated cryptococcal disease after Bruton tyrosine kinase inhibitor therapy: A brief review in the Australian context
JAAD Case Rep
.
2021 Apr 26:13:43-45.
doi: 10.1016/j.jdcr.2021.04.022.
eCollection 2021 Jul.
Authors
Nicholas Van Rooij
1
2
3
,
Jesse Johnston
1
,
Rohan Mortimore
1
,
Ivan Robertson
1
Affiliations
1
The Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
2
School of Medicine, Griffith University, Southport, Queensland, Australia.
3
Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia.
PMID:
34136624
PMCID:
PMC8182371
DOI:
10.1016/j.jdcr.2021.04.022
No abstract available
Keywords:
BTK, Bruton tyrosine kinase; dermatology; drug reaction; eruption; hematology; ibrutinib.
Publication types
Case Reports